Since the latest report about an altered secretion of VEGF after EGFR activating mutation occurring in NSCLC cells [29], we sought to investigate whether aumolertinib influences the secretion of VEGF from H1975 and HCC827. This evidence concerns the gene EGFR and non-small cell lung carcinoma.